Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
5
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
SELVAX PTY LTD
ABN18009263816
Legal entities
Show as table · Selvax Pty Ltd: 1 registry entity
| SELVAX PTY LTD | ABN 18009263816 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Selvax is a preclinical stage company developing a safe, effective, immunological-based treatment for a range of hard to treat solid tumours.
It was established in 2015 from research at Curtin University that achieved a major breakthrough in the treatment of cancer by harnessing and amplifying the body’s anti-tumour immune response.
Our lead candidate combines two immunological agents, which are administered directly into the tumour site causing regression of solid tumours (including chemotherapy-resistant) with minimal toxic side effects.
The complete tumour clearance rates achieved in small animal models with eight different solid tumours ranged from 90% for colorectal cancer to 30% for renal cancers. Data showed no tumour recurrence for the life of the animal and clearance of a second tumour in another part of the body (abscopal metastatic model).
An animal health product also being developed for treating dogs with cancer has achieved positive results in a trial conducted in collaboration with Perth Veterinary Specialists, a specialist oncology clinic.
The Selvax approach differs from standard chemotherapy and radiological treatments in that its goal is to stimulate the patient’s own immune system to kill the cancer. The treatment effectively acts as a 'vaccine' against recurrence of the cancer.
Specialties
All 13 specialties
- biotechnology
- antibody
- immunotherapy
- cancer
- animal health
- research
- drug development
- biologics
- preclinical
- sarcoma
- solid tumour
- immuno-oncology
- melanoma
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUPerth, WAPrimary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Selvax Pty Ltd?
One Western Australia entity on the ABR: SELVAX PTY LTD (ABN 18 009 263 816), high confidence.
How many people work at Selvax Pty Ltd?
5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Selvax Pty Ltd have offices?
One address on record, Australia only. Primary: Perth, WA.
Has Selvax Pty Ltd raised funding?
None linked to this brand.
What does Selvax Pty Ltd list as its specialties?
13 tags on the brand's own list, among them animal health, research and cancer.
Which companies are listed alongside Selvax Pty Ltd?
2 profiles list Selvax Pty Ltd as a peer — 43rd percentile in Biotechnology. It lists four peers of its own. Grow Impact and Avicena Systems list it back.